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Dear Editor,
We recently read the article ’’Monosodium glutamate
neonatal treatment induces cardiovascular autonomic func-
tion changes in rodents’’ by Signora Peres Konrad et al. with
great interest(1). These authors concluded that obesity
induced by neonatal monosodium glutamate treatment
impairs cardiac autonomic function and most likely
contributes to increased arterial pressure and insulin
resistance in rats. The authors are to be commended for
contributing such a well-designed and successfully pre-
sented study. We believe that these findings will guide
further study of obesity and metabolic syndrome (MS).
Obesity is a growing public health problem, and meta-
bolic syndrome is an important risk factor for cardiovas-
cular diseases (2,3). Although it is correct that this study
should be emphasized in terms of these factors, we believe
that obesity and MS induced in rats with monosodium
glutamate may differ from any hereditary or acquired
obesity and from MS in humans, i.e., that the enzymatic
pathways utilized by and the physiologic effects resulting
from these two entities may be different. These differences
may affect treatment success, and we believe that the study
results should be assessed with this perspective in mind.
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